Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese NSCLC patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relationship between intestinal flora structure and metabolite analysis and immunotherapy efficacy in Chinese
NSCLC
patients
Authors
Keywords
-
Journal
Thoracic Cancer
Volume 11, Issue 6, Pages 1621-1632
Publisher
Wiley
Online
2020-04-24
DOI
10.1111/1759-7714.13442
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids
- (2019) Kai Wang et al. Cell Reports
- The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients
- (2019) Yueping Jin et al. Journal of Thoracic Oncology
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Regional variation limits applications of healthy gut microbiome reference ranges and disease models
- (2018) Yan He et al. NATURE MEDICINE
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity
- (2017) Vinod K. Gupta et al. Frontiers in Microbiology
- Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy
- (2017) Sivaranjani Namasivayam et al. Microbiome
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Microbiome-wide association studies link dynamic microbial consortia to disease
- (2016) Jack A. Gilbert et al. NATURE
- Accounting for reciprocal host–microbiome interactions in experimental science
- (2016) Thaddeus S. Stappenbeck et al. NATURE
- Population-level analysis of gut microbiome variation
- (2016) Gwen Falony et al. SCIENCE
- PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis
- (2016) Ji Liang et al. Nature Communications
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human gut microbiota and its relationship to health and disease
- (2011) Taylor C Wallace et al. NUTRITION REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More